Hemagglutinin
Influenza A virus (strain swl A/California/04/2009 H1N1)
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Other combination Heteromer Protein × 12 其他Polymer 3 PDB declaration: dodecameric(12) Consistent with protein copy count | Chain A; UniProt 18–341 | Fragment:HA1 subdomain (UNP residues 18-344) | Hemagglutinin × 3 (A0A1D5AKA4) GC_w13_B, Fab heavy chain × 3 GC_w13_B, Fab light chain × 3 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 3 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 MG MAGNESIUM ION × 6 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;293 K;0.2 M sodium acetate, pH 6.2, 20% PEG3350 | Resolution 3.25 Å R-free 0.287 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 8TXM | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 24KR Structural basis of influenza A virus neutralization by broadly active single-domain antibody G2.3 recognizing glycosylated epitope within hemagglutinin stem Deposited 2026-03-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain A
1–518(518 aa)
Chain B
1–518(518 aa)
Chain C
1–518(518 aa)
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY mmCIF provides none of the parsed conditions | Resolution 2.53 Å |
| 3AL4 Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus Deposited 2010-07-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
18–344(327 aa)
Fragment:UNP residues 18-344
Chain B
345–520(176 aa)
Fragment:UNP residues 345-520
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;10% PEG 6000, 5% MPD, 0.1M MES, PH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 2.87 Å R-free 0.270 |
| 3AL4 Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus Deposited 2010-07-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
18–344(327 aa)
Fragment:UNP residues 18-344
Chain D
345–520(176 aa)
Fragment:UNP residues 345-520
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;10% PEG 6000, 5% MPD, 0.1M MES, PH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 2.87 Å R-free 0.270 |
| 3AL4 Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus Deposited 2010-07-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Other combination Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain E
18–344(327 aa)
Fragment:UNP residues 18-344
Chain F
345–520(176 aa)
Fragment:UNP residues 345-520
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;10% PEG 6000, 5% MPD, 0.1M MES, PH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 2.87 Å R-free 0.270 |
| 3AL4 Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus Deposited 2010-07-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain G
18–344(327 aa)
Fragment:UNP residues 18-344
Chain H
345–520(176 aa)
Fragment:UNP residues 345-520
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;10% PEG 6000, 5% MPD, 0.1M MES, PH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 2.87 Å R-free 0.270 |
| 3AL4 Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus Deposited 2010-07-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Other combination Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain I
18–344(327 aa)
Fragment:UNP residues 18-344
Chain J
345–520(176 aa)
Fragment:UNP residues 345-520
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;10% PEG 6000, 5% MPD, 0.1M MES, PH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 2.87 Å R-free 0.270 |
| 3AL4 Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus Deposited 2010-07-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 6 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain K
18–344(327 aa)
Fragment:UNP residues 18-344
Chain L
345–520(176 aa)
Fragment:UNP residues 345-520
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;10% PEG 6000, 5% MPD, 0.1M MES, PH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 2.87 Å R-free 0.270 |
| 3LZG Crystal structure of a 2009 H1N1 influenza virus hemagglutinin Deposited 2010-03-01 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain B
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
Chain C
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain D
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
Chain E
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain F
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.8;295.5 K;27% PEG-MME 2000, 0.1M Tris pH 8.8, VAPOR DIFFUSION, SITTING DROP, temperature 295.5K
|
Resolution 2.60 Å R-free 0.252 |
| 3LZG Crystal structure of a 2009 H1N1 influenza virus hemagglutinin Deposited 2010-03-01 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain G
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain H
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
Chain I
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain J
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
Chain K
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain L
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.8;295.5 K;27% PEG-MME 2000, 0.1M Tris pH 8.8, VAPOR DIFFUSION, SITTING DROP, temperature 295.5K
|
Resolution 2.60 Å R-free 0.252 |
| 3UBE Influenza hemagglutinin from the 2009 pandemic in complex with ligand LSTc Deposited 2011-10-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain B
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
Chain C
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain D
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
Chain E
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain F
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
|
Mutation:G205C, R220C Mutation:G205C, R220C Mutation:G205C, R220C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.8;295.5 K;27% PEG-MME 2000, 0.1M Tris pH 8.8, VAPOR DIFFUSION, SITTING DROP, temperature 295.5K
|
Resolution 2.15 Å R-free 0.252 |
| 3UBE Influenza hemagglutinin from the 2009 pandemic in complex with ligand LSTc Deposited 2011-10-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain G
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain H
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
Chain I
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain J
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
Chain K
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain L
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
|
Mutation:G205C, R220C Mutation:G205C, R220C Mutation:G205C, R220C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 SIA N-acetyl-alpha-neuraminic acid × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.8;295.5 K;27% PEG-MME 2000, 0.1M Tris pH 8.8, VAPOR DIFFUSION, SITTING DROP, temperature 295.5K
|
Resolution 2.15 Å R-free 0.252 |
| 3UBJ Influenza hemagglutinin from the 2009 pandemic in complex with ligand LSTa Deposited 2011-10-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain B
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
Chain C
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain D
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
Chain E
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain F
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
|
Mutation:G205C, R220C Mutation:G205C, R220C Mutation:G205C, R220C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.8;295.5 K;27% PEG-MME 2000, 0.1M Tris pH 8.8, VAPOR DIFFUSION, SITTING DROP, temperature 295.5K
|
Resolution 2.25 Å R-free 0.252 |
| 3UBJ Influenza hemagglutinin from the 2009 pandemic in complex with ligand LSTa Deposited 2011-10-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain G
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain H
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
Chain I
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain J
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
Chain K
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain L
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
|
Mutation:G205C, R220C Mutation:G205C, R220C Mutation:G205C, R220C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.8;295.5 K;27% PEG-MME 2000, 0.1M Tris pH 8.8, VAPOR DIFFUSION, SITTING DROP, temperature 295.5K
|
Resolution 2.25 Å R-free 0.252 |
| 3UBN Influenza hemagglutinin from the 2009 pandemic in complex with ligand 6SLN Deposited 2011-10-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain B
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
Chain C
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain D
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
Chain E
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain F
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
|
Mutation:G205C, R220C Mutation:G205C, R220C Mutation:G205C, R220C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.8;295.5 K;27% PEG-MME 2000, 0.1M Tris pH 8.8, VAPOR DIFFUSION, SITTING DROP, temperature 295.5K
|
Resolution 2.51 Å R-free 0.253 |
| 3UBN Influenza hemagglutinin from the 2009 pandemic in complex with ligand 6SLN Deposited 2011-10-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain G
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain H
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
Chain I
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain J
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
Chain K
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain L
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
|
Mutation:G205C, R220C Mutation:G205C, R220C Mutation:G205C, R220C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.8;295.5 K;27% PEG-MME 2000, 0.1M Tris pH 8.8, VAPOR DIFFUSION, SITTING DROP, temperature 295.5K
|
Resolution 2.51 Å R-free 0.253 |
| 3UBQ Influenza hemagglutinin from the 2009 pandemic in complex with ligand 3SLN Deposited 2011-10-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain B
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
Chain C
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain D
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
Chain E
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain F
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
|
Mutation:G205C, R220C Mutation:G205C, R220C Mutation:G205C, R220C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.8;295.5 K;27% PEG-MME 2000, 0.1M Tris pH 8.8, VAPOR DIFFUSION, SITTING DROP, temperature 295.5K
|
Resolution 2.00 Å R-free 0.249 |
| 3UBQ Influenza hemagglutinin from the 2009 pandemic in complex with ligand 3SLN Deposited 2011-10-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain G
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain H
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
Chain I
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain J
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
Chain K
18–344(327 aa)
Fragment:Ectodomain HA1, residues 18-344
Chain L
345–518(174 aa)
Fragment:Ectodomain HA2, residues 345-520
|
Mutation:G205C, R220C Mutation:G205C, R220C Mutation:G205C, R220C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.8;295.5 K;27% PEG-MME 2000, 0.1M Tris pH 8.8, VAPOR DIFFUSION, SITTING DROP, temperature 295.5K
|
Resolution 2.00 Å R-free 0.249 |
| 3UYW Crystal structures of globular head of 2009 pandemic H1N1 hemagglutinin Deposited 2011-12-06 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
65–278(214 aa)
Fragment:UNP residues 65-278
|
Not recorded | TAU 2-AMINOETHANESULFONIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;10% PEG 6000, 5% MPD, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 1.90 Å R-free 0.198 |
| 3UYW Crystal structures of globular head of 2009 pandemic H1N1 hemagglutinin Deposited 2011-12-06 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
65–278(214 aa)
Fragment:UNP residues 65-278
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;10% PEG 6000, 5% MPD, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 1.90 Å R-free 0.198 |
| 3UYW Crystal structures of globular head of 2009 pandemic H1N1 hemagglutinin Deposited 2011-12-06 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain C
65–278(214 aa)
Fragment:UNP residues 65-278
|
Not recorded | TAU 2-AMINOETHANESULFONIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;10% PEG 6000, 5% MPD, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 1.90 Å R-free 0.198 |
| 3UYW Crystal structures of globular head of 2009 pandemic H1N1 hemagglutinin Deposited 2011-12-06 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain D
65–278(214 aa)
Fragment:UNP residues 65-278
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;10% PEG 6000, 5% MPD, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 1.90 Å R-free 0.198 |
| 3UYX Crystal structures of globular head of 2009 pandemic H1N1 hemagglutinin Deposited 2011-12-06 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
65–278(214 aa)
Fragment:UNP residues 65-278
|
Mutation:D228G | NO3 NITRATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.2;291 K;20% PEG 3350, 0.2M ammonium nitrate, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 1.80 Å R-free 0.201 |
| 3UYX Crystal structures of globular head of 2009 pandemic H1N1 hemagglutinin Deposited 2011-12-06 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
65–278(214 aa)
Fragment:UNP residues 65-278
|
Mutation:D228G | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.2;291 K;20% PEG 3350, 0.2M ammonium nitrate, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 1.80 Å R-free 0.201 |
| 3ZTN STRUCTURE OF INFLUENZA A NEUTRALIZING ANTIBODY SELECTED FROM CULTURES OF SINGLE HUMAN PLASMA CELLS IN COMPLEX WITH HUMAN H1 INFLUENZA HAEMAGGLUTININ. Deposited 2011-07-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric |
Chain A
18–344(327 aa)
Fragment:HA1, RESIDUES 18-344
Chain B
345–520(176 aa)
Fragment:HA2, RESIDUES 345-520
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 SO4 SULFATE ION × 15 GOL GLYCEROL × 3 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 3.00 Å R-free 0.289 |
| 4JTV Crystal structure of 2009 pandemic influenza virus hemagglutinin complexed with human receptor analogue LSTc Deposited 2013-03-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
18–338(321 aa)
Fragment:UNP residues 18-338
Chain B
345–506(162 aa)
Fragment:UNP residues 345-506
Chain C
18–338(321 aa)
Fragment:UNP residues 18-338
Chain D
345–506(162 aa)
Fragment:UNP residues 345-506
Chain E
18–338(321 aa)
Fragment:UNP residues 18-338
Chain F
345–506(162 aa)
Fragment:UNP residues 345-506
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;10% PEG6000, 5% MPD, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 3.00 Å R-free 0.275 |
| 4JTV Crystal structure of 2009 pandemic influenza virus hemagglutinin complexed with human receptor analogue LSTc Deposited 2013-03-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain G
18–338(321 aa)
Fragment:UNP residues 18-338
Chain H
345–506(162 aa)
Fragment:UNP residues 345-506
Chain I
18–338(321 aa)
Fragment:UNP residues 18-338
Chain J
345–506(162 aa)
Fragment:UNP residues 345-506
Chain K
18–338(321 aa)
Fragment:UNP residues 18-338
Chain L
345–506(162 aa)
Fragment:UNP residues 345-506
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 SIA N-acetyl-alpha-neuraminic acid × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;10% PEG6000, 5% MPD, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 3.00 Å R-free 0.275 |
| 4JTX Crystal structure of 2009 pandemic influenza virus hemagglutinin mutant D225E Deposited 2013-03-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
18–339(322 aa)
Fragment:UNP residues 18-339
Chain B
345–510(166 aa)
Fragment:UNP residues 345-510
Chain C
18–339(322 aa)
Fragment:UNP residues 18-339
Chain D
345–510(166 aa)
Fragment:UNP residues 345-510
Chain E
18–339(322 aa)
Fragment:UNP residues 18-339
Chain F
345–510(166 aa)
Fragment:UNP residues 345-510
|
Mutation:D228E Mutation:D228E Mutation:D228E | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;10% PEG 6000, 5% MPD, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 3.00 Å R-free 0.243 |
| 4JTX Crystal structure of 2009 pandemic influenza virus hemagglutinin mutant D225E Deposited 2013-03-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain G
18–339(322 aa)
Fragment:UNP residues 18-339
Chain H
345–510(166 aa)
Fragment:UNP residues 345-510
Chain I
18–339(322 aa)
Fragment:UNP residues 18-339
Chain J
345–510(166 aa)
Fragment:UNP residues 345-510
Chain K
18–339(322 aa)
Fragment:UNP residues 18-339
Chain L
345–510(166 aa)
Fragment:UNP residues 345-510
|
Mutation:D228E Mutation:D228E Mutation:D228E | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;10% PEG 6000, 5% MPD, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 3.00 Å R-free 0.243 |
| 4JU0 Crystal structure of 2009 pandemic influenza virus hemagglutinin mutant D225E complexed with human receptor analogue LSTc Deposited 2013-03-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
18–339(322 aa)
Fragment:UNP residues 18-339
Chain B
345–508(164 aa)
Fragment:UNP residues 345-508
Chain C
18–339(322 aa)
Fragment:UNP residues 18-339
Chain D
345–508(164 aa)
Fragment:UNP residues 345-508
Chain E
18–339(322 aa)
Fragment:UNP residues 18-339
Chain F
345–508(164 aa)
Fragment:UNP residues 345-508
|
Mutation:D228E Mutation:D228E Mutation:D228E | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;10% PEG 6000, 5% MPD, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 2.91 Å R-free 0.283 |
| 4JU0 Crystal structure of 2009 pandemic influenza virus hemagglutinin mutant D225E complexed with human receptor analogue LSTc Deposited 2013-03-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain G
18–339(322 aa)
Fragment:UNP residues 18-339
Chain H
345–508(164 aa)
Fragment:UNP residues 345-508
Chain I
18–339(322 aa)
Fragment:UNP residues 18-339
Chain J
345–508(164 aa)
Fragment:UNP residues 345-508
Chain K
18–339(322 aa)
Fragment:UNP residues 18-339
Chain L
345–508(164 aa)
Fragment:UNP residues 345-508
|
Mutation:D228E Mutation:D228E Mutation:D228E | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 SIA N-acetyl-alpha-neuraminic acid × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;10% PEG 6000, 5% MPD, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 2.91 Å R-free 0.283 |
| 4M4Y Crystal structure of a 2009 H1N1 influenza virus hemagglutinin with a stabilization mutation HA2 E47G Deposited 2013-08-07 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
18–344(327 aa)
Fragment:ectodomain (residues 18-344)
Chain B
345–518(174 aa)
Fragment:ectodomain (residues 345-518)
Chain C
18–344(327 aa)
Fragment:ectodomain (residues 18-344)
Chain D
345–518(174 aa)
Fragment:ectodomain (residues 345-518)
Chain E
18–344(327 aa)
Fragment:ectodomain (residues 18-344)
Chain F
345–518(174 aa)
Fragment:ectodomain (residues 345-518)
|
Mutation:E47G Mutation:E47G Mutation:E47G | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.8;295 K;0.1 M Tris, pH 8.8, 25% w/v MPEG2000, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 2.20 Å R-free 0.232 |
| 5GJS Crystal structure of H1 hemagglutinin from A/California/04/2009 in complex with a neutralizing antibody 3E1 Deposited 2016-07-01 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric |
Chain A
18–344(327 aa)
Fragment:UNP residues 18-344
Chain B
345–520(176 aa)
Fragment:neutralizing antibody 3E1
|
Mutation:G212C, R227C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1M MES and 16% PEG 550MME
|
Resolution 2.90 Å R-free 0.303 |
| 5K9O Crystal structure of multidonor HV1-18+HD3-9 class broadly neutralizing Influenza A antibody 31.b.09 in complex with Hemagglutinin H1 A/California/04/2009 Deposited 2016-06-01 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 6 PDB declaration: hexameric |
Chain F
18–520(503 aa)
Chain I
18–520(503 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1M imidazole, pH 6.5, 0.1M MgCl2, 1.75M NaCl, and 15% PEG-3350
|
Resolution 3.39 Å R-free 0.346 |
| 5WKO Crystal structure of antibody 27F3 recognizing the HA from A/California/04/2009 (H1N1) influenza virus Deposited 2017-07-25 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 12 PDB declaration: dodecameric |
Chain M
18–344(327 aa)
Chain N
18–344(327 aa)
Chain O
18–344(327 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277.15 K;1.6 M ammonium sulfate,
0.1 M citric acid pH 4.0
|
Resolution 3.49 Å R-free 0.268 |
| 5WKO Crystal structure of antibody 27F3 recognizing the HA from A/California/04/2009 (H1N1) influenza virus Deposited 2017-07-25 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Insufficient information Heteromer;Protein × 12 PDB declaration: dodecameric |
Chain S
18–344(327 aa)
Chain T
18–344(327 aa)
Chain U
18–344(327 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277.15 K;1.6 M ammonium sulfate,
0.1 M citric acid pH 4.0
|
Resolution 3.49 Å R-free 0.268 |
| 7FAH Immune complex of head region of CA09 HA and neutralizing antibody 12H5 Deposited 2021-07-06 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain A
18–518(501 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;0.1M MES pH 6.5, 13% (w/v) PEG 2000
|
Resolution 3.15 Å R-free 0.289 |
| 7FAH Immune complex of head region of CA09 HA and neutralizing antibody 12H5 Deposited 2021-07-06 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain B
18–518(501 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;0.1M MES pH 6.5, 13% (w/v) PEG 2000
|
Resolution 3.15 Å R-free 0.289 |
| 7MEM CryoEM structure of monoclonal Fab 045-09 2B05 binding the lateral patch of influenza virus H1 HA Deposited 2021-04-06 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric |
Chain A
345–518(174 aa)
Chain B
345–518(174 aa)
Chain C
18–344(327 aa)
Chain D
345–518(174 aa)
Chain E
18–344(327 aa)
Chain F
18–344(327 aa)
|
Mutation:E47G Mutation:E47G Mutation:E47G | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4;TBS + LMNG
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å |
| 7T3D CryoEM map of anchor 222-1C06 Fab and lateral patch 2B05 Fab binding H1 HA Deposited 2021-12-07 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric |
Chain A
18–344(327 aa)
Chain B
345–518(174 aa)
Chain E
18–344(327 aa)
Chain F
18–344(327 aa)
Chain G
345–518(174 aa)
Chain I
345–518(174 aa)
|
Mutation:E47K Mutation:E47K Mutation:E47K | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 15 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4;Tris-buffered saline
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.38 Å |
| 8TXP Crystal structure of 05.GC.w13.01 Fab in complex with H1 HA from A/California/04/2009(H1N1) Deposited 2023-08-24 | Different construct Different oligomeric state Different ligand/ion Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric |
Chain A
18–344(327 aa)
Fragment:HA1 subdomain (UNP residues 18-344)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.2 M sodium acetate, pH 6.2, 20% PEG3350
|
Resolution 2.75 Å R-free 0.292 |
21 other PDB entries and 40 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | C3W5S1_I09A0 |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 5–328; UniProt 18–341 |